United Therapeutics Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
All right. Welcome, everyone, to our 30th Annual Healthcare Conference. Credit Suisse. I'm Tiago Fauth, I'm a biotech analyst here at Credit Suisse, and we're joined today by United Therapeutics. We have Michael Benkowitz. We have Dewey, and we have James Edgemond as well.
I'm just going to hand it off to Dewey, so he can read some forward-looking statements, language and when we can jump right in.
Thank you, Tiago, and good morning, everyone. Our remarks today may include forward-looking information about our business. Please see our SEC filings especially Forms 10-K and 10-Q for risks and uncertainties that could cause actual results to differ.
And with that, I'll turn it back over to you, Tiago.
© -
Perfect. As usual, we can kick it
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |